PlainRecalls
FDA Drug Critical Class I Ongoing

Treprostinil Injection, 20 mg/20 mL (1 mg/mL), For Subcutaneous or Intravenous Infusion Only, 20 mL Multiple-Dose Vial, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-206-01

Reported: April 3, 2024 Initiated: March 4, 2024 #D-0429-2024

Product Description

Treprostinil Injection, 20 mg/20 mL (1 mg/mL), For Subcutaneous or Intravenous Infusion Only, 20 mL Multiple-Dose Vial, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-206-01

Reason for Recall

Presence of Particulate Matter.

Details

Recalling Firm
Par Sterile Products LLC
Units Affected
466 vials
Distribution
Nationwide in the USA
Location
Rochester, MI

Frequently Asked Questions

What product was recalled?
Treprostinil Injection, 20 mg/20 mL (1 mg/mL), For Subcutaneous or Intravenous Infusion Only, 20 mL Multiple-Dose Vial, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-206-01. Recalled by Par Sterile Products LLC. Units affected: 466 vials.
Why was this product recalled?
Presence of Particulate Matter.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 3, 2024. Severity: Critical. Recall number: D-0429-2024.